Related Experiment Videos
Agalsidase alfa: specific treatment for Fabry disease
1Royal Free Hospital, London NW3 2QG.
Hospital Medicine (London, England : 1998)
|July 5, 2002
Abstract:
Fabry disease is a rare genetic lysosomal storage disorder characterized by a deficiency of the enzyme alpha-galactosidase A. The recent availability of enzyme-replacement therapy with agalsidase alfa offers specific treatment for this serious, progressive condition.